#USA #San Diego #biotechnology #Primrose Bio #Function Generator

Primrose Bio's Revolutionary Function Generator™

Primrose Bio, Inc., based in San Diego, has recently made significant strides in the field of biotechnology with the announcement of its latest advancement—the Function Generator™. This cutting-edge technology, which utilizes combinatorial genetic techniques, has been highlighted in a peer-reviewed study published in Proceedings of the National Academy of Sciences (PNAS). The study showcases an innovative approach to engineering complex microbial traits by generating vast libraries of gene combinations.

A New Dimension in Genetic Engineering

The Function Generator™ offers a novel combinatorial gene fusion methodology. This technique allows researchers to combine protein-coding sequences from across the entire genome, resulting in the creation of tens of millions of gene variations. The proof-of-concept study conducted by Primrose identified over 20 million distinct gene combinations derived from more than 5,000 protein-coding sequences of Saccharomyces cerevisiae, a species of budding yeast.

Among the findings, the study successfully uncovered gain-of-function variants that demonstrate an ability to resist toxic metal ions, which is a monumental step forward in microbial strain engineering. According to Drew Burch, the CEO of Primrose Bio, the Function Generator offers a scalable and diverse solution to tackle complex challenges faced in strain and cell line engineering. This leap expands the existing capabilities in microbial design and holds potential applications in various fields, from bioprocessing to agriculture.

The Science Behind Function Generator™

The groundbreaking technology introduced in this study highlights the power of synthesizing genetic information at a genome-wide scale. By fusing protein-coding sequences, Primrose Bio has been able to pioneer new genetic architectures that produce phenotypes that might not be observable from traditional individual gene modifications. Dr. Helge Zieler, who serves as a scientific advisor to Primrose, emphasizes that this technology is not only transformative for microbes but also lays the groundwork for enhancements in higher organisms and aids in biologic drug discovery.

The advancements in microbial strain engineering facilitated by the Function Generator™ also extend to existing applications in Primrose's proprietary Pfenex Expression Technology®, which focuses on augmenting microbial productivity, robustness, and performance in secretion. These improvements are crucial for enhancing yield efficiencies in product manufacturing within the biotechnology industry.

Implications for the Future of Biotechnology

As the biotechnology sector continues to evolve at a rapid pace, Primrose Bio stands out by addressing critical gaps in production systems with scalable and efficient solutions. With technologies such as the Pfenex Expression Technology® and improvements in enzyme functions like Prima RNApols®, Primrose is solidifying its place as a leader in this competitive field.

In an era where biotechnology plays a pivotal role in addressing global challenges, such as food security and biopharmaceutical production, advancements like the Function Generator™ represent a beacon of innovation. As it gains traction within the scientific community and industry, the broader implications of Primrose’s work may soon influence not only microbial strain improvement but may also redefine how biological systems are engineered—ultimately leading to breakthroughs that could enhance human health and well-being.

For more detailed insights and to access the full publication, please refer to the article in PNAS at this link.

About Primrose Bio, Inc.

Primrose Bio is committed to developing and commercializing validated technologies aimed at minimizing inefficiencies in production systems, providing scalable manufacturing solutions to industry-wide challenges. With a suite of products including the Pfenex Expression Technology® and its CRM197 carrier protein application for conjugate vaccines, Primrose is at the forefront of biopharmaceutical advancements utilized by leading pharmaceutical companies worldwide. For further information about their innovative solutions, visit www.primrosebio.com.